Several studies have shown that pro-inflammatory cytokines and their receptors are potential GVHD biomarkers, but some factors other than GVHD contribute to these cytokines’ release (e.g., TNF-α, TNFR1, IL-6) [5,6,32]. The gene discussed is IL6; the disease is graft versus host disease.